579475-29-9

Basic information

• Product Name: 3-Bromo-6-(cyclopropyl)pyridine
• Synonyms: 3-Bromo-6-(cyclopropyl)pyridine
• CAS NO: 579475-29-9
• Molecular Formula: C₈H₈BrN
• Molecular Weight: 198.062
• Mol File: 579475-29-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 242.9±28.0 °C(Predicted)
• Appearance: /
• Density: 1.561±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.55±0.22(Predicted)
• CAS DataBase Reference: 3-Bromo-6-(cyclopropyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-6-(cyclopropyl)pyridine(579475-29-9)
• EPA Substance Registry System: 3-Bromo-6-(cyclopropyl)pyridine(579475-29-9)

Safety Data

• Hazardous Substances Data: 579475-29-9(Hazardous Substances Data)

Usage

General Description

3-Bromo-6-(cyclopropyl)pyridine is a chemical compound with the molecular formula C8H7BrN. It is a pyridine derivative with a bromine atom at the 3-position and a cyclopropyl group at the 6-position. 3-Bromo-6-(cyclopropyl)pyridine is used in organic synthesis as a building block for the preparation of various pharmaceuticals and agrochemicals. It has been studied for its potential biological activities and is utilized in the development of new drugs. 3-Bromo-6-(cyclopropyl)pyridine is a valuable intermediate in the production of drugs and agrochemicals, making it an important compound in the field of medicinal and agricultural chemistry.

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 23719-80-4 cyclopropylmagnesium bromide 
• 203861-73-8 cyclopropylzinc chloride 
• 4333-56-6 cyclopropyl bromide 

Downstream Products

• 579475-27-7 3-(6-cyclopropyl-pyridin-3-yl)-benzonitrile 
• 893567-09-4 2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 

Relevant articles and documents

HETEROCYCLIC COMPOUND AS CSF-1R INHIBITOR AND USE THEREOF

The present invention relates to a class of isoindolinone derivatives and use thereof in the preparation of a medicament for treating diseases associated with a novel colony stimulating factor 1 receptor (CSF-1R) inhibitor. In particular, the present invention relates to a compound of formula (I) and a pharmaceutically acceptable salt thereof or a stereoisomer thereof.

Acetylenyl-pyrazolo-pyrimidine derivatives

The present invention relates to compounds of formula (I): wherein R1 to R3, A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for the manufacture of such compounds, pharmaceutical compositions containing them, and methods for treating CNS disorders.

COMBINATION OF MGLUR2 ANTAGONIST AND ACHE INHIBITOR FOR TREATMENT OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS

The present invention relates to a method of treatment or prevention of acute and/or chronic neurological disorders, to a pharmaceutical composition comprising an inhibitor of acetylcholinesterase (AChE inhibitor) and a metabotropic Glutamate receptor 2 antagonist (mGluR2 antagonist), to the use of an AChE inhibitor and a mGluR2 antagonist in the preparation of a medicament, and. to kits comprising an AChE inhibitor and a mGluR2 antagonist.